Cover Image

Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

Kenichi Morikawa, Akihisa Nakamura, Tomoe Shimazaki, Naoya Sakamoto Department of Gastroenterology and Hepatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan Abstract: Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious...

Full description

Saved in:

Bibliographic Details
Main Authors:	Morikawa K (Author), Nakamura A (Author), Shimazaki T (Author), Sakamoto N (Author)
Format:	Book
Published:	Dove Medical Press, 2018-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review
by: Jinyu Liu, et al.
Published: (2022)

Spotlight on grazoprevir—elbasvir once-daily combination and its potential in the treatment of hepatitis C
by: Suraweera D, et al.
Published: (2016)

Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam
by: Chizoba Nwankwo, et al.
Published: (2019)

Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
by: Jinyu Liu, et al.
Published: (2021)

Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy
by: Hézode C, et al.
Published: (2019)

P64 Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir
by: N. Reau, et al.
Published: (2017)

A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
by: Hsuan-Yu Hung, et al.
Published: (2021)

Development and Validation of new RP-HPLC Method for the Simultaneous Estimation of Elbasvir and Grazoprevir in Combined Pharmaceutical Dosage Form
by: P Seetharamaiah, et al.
Published: (2023)

A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants
by: Li H, et al.
Published: (2020)

O21 HCV reinfection and injecting risk behaviour following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR three year follow-up study
by: G. Dore, et al.
Published: (2017)

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
by: Melissa K Osborn
Published: (2009)

Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence
by: Brigham D, et al.
Published: (2024)

Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta
by: Alaa Eldeen M Hashim, et al.
Published: (2020)

Efficacy of Interferonfree treatment for patients with chronic hepatitis C virus
by: Valeria Muntean, et al.
Published: (2019)

High efficacy and safety of direct‐acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam
by: Thong Duy Vo, et al.
Published: (2024)

Prospects for current hepatitis C treatment failures
by: Vicente Soriano
Published: (2016)

Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities-A Brief Report
by: Maria Pokorska-Śpiewak, et al.
Published: (2022)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
by: Patrick A Schweizer, et al.
Published: (2011)

Chronic hepatitis C: future treatment
by: Wendt A, et al.
Published: (2014)

Metamizole: Current status of the safety and efficacy
by: Miljković Milijana N., et al.
Published: (2018)

Nuevos avances en el manejo de la hepatitis C Current advances in hepatitis C treatment
by: Laura E. Cisneros-Garza
Published: (2011)

Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
by: Hussien Ahmed, et al.
Published: (2018)

Managing pediatric hepatitis C: current and emerging treatment options
by: Wikrom Karnsakul, et al.
Published: (2009)

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
by: Pajaree Chariyavilaskul, et al.
Published: (2024)

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study
by: J. Grebely, et al.
Published: (2017)

VITAMIN D LEVELS IN PATIENTS WITH CHRONIC HEPATITIS B, CHRONIC HEPATITIS C, AND HEALTH CONTROLS
by: Biljana Ilkovska, et al.
Published: (2019)

Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine
by: Eduardo Guimarães Pereira, et al.
Published: (2016)

Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysis
by: Wisit Cheungpasitporn, et al.
Published: (2017)

The strategies of drug supply for patients with chronic hepatitis C
by: E. V. Kornilova, et al.
Published: (2017)

Current characteristics of chronic hepatitis B in Egypt
by: Maha M Elsabaawy, et al.
Published: (2019)

Interaction of hepatitis C virus with the immune system in pregnant women with chronic hepatitis C
by: A. P. Tsibulkin, et al.
Published: (2019)

Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis
by: Mai Abdelmen, et al.
Published: (2020)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019)

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
by: Kuroda Masahiko, et al.
Published: (2010)

FEATURES OF CLINICAL COURSE AND MORPHOLOGICAL CHANGES OF CHRONIC HEPATITIS C IN INFANTS
by: M. M. Kotovich, et al.
Published: (2015)

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China
by: Huan Xia, et al.
Published: (2020)

Eczema craquelé associated with antiviral treatment for chronic hepatitis C
by: Edla Polsinelli Bedin Mascarin do Vale, et al.
Published: (2017)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014)

Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety
by: Kim DY, et al.
Published: (2017)